Embolization of Arteriovenous Malformation with Diluted Mixture of NBCA

Tamatani, Shinichi; Koike, Tetsuo; Ito, Yasushi; Tanaka, Ryuichi

doi:10.1177/15910199000060s129

Cited by 21 publications

(13 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Situ Polymerization -nBCA N-butyl-2-cyanoacrylate (nBCA) (e.g., TruFill), commonly known as "glue," is a clear, free-flowing liquid that has used for embolization since the mid-1980s. [292] It is also widely used in wound healing since it provides an antimicrobial barrier with 99% efficacy for at least 72 h. [11b] nBCA has relatively low viscosity of about 10 mPa s. [293] It adheres to tissue by in situ polymerization upon contact with tissue fluid, an ionic and high-pH environment, creating a glue effect. The polymerization process is anionic (induced by OH − ) and exothermic (released heat is up to 80 °C and can be very painful).…”

Section: Droplet Agentsmentioning

confidence: 99%

Advances in Biomaterials and Technologies for Vascular Embolization

et al. 2019

View full text Add to dashboard Cite

Minimally invasive transcatheter embolization is a common nonsurgical procedure in interventional radiology used for the deliberate occlusion of blood vessels for the treatment of diseased or injured vasculature. A wide variety of embolic agents including metallic coils, calibrated microspheres, and liquids are available for clinical practice. Additionally, advances in biomaterials, such as shapememory foams, biodegradable polymers, and in situ gelling solutions have led to the development of novel pre-clinical embolic agents. The aim here is to provide a comprehensive overview of current and emerging technologies in endovascular embolization with respect to devices, materials, mechanisms, and design guidelines. Limitations and challenges in embolic materials are also discussed to promote advancement in the field.

show abstract

Section: Droplet Agentsmentioning

confidence: 99%

Advances in Biomaterials and Technologies for Vascular Embolization

et al. 2019

View full text Add to dashboard Cite

show abstract

“…Alternative theories include capillary instability and weakness as a consequence of neovascularisation 41 and occlusive hyperaemia due to obstruction of adjacent venous outflow and stagnant arterial flow in previous AVM feeding vessels 42 . It is recommended that the blood pressure is maintained at 15-20% below the patient's baseline blood pressure but this is not evidencebased 43,44 . Diligent avoidance of hypertension and maintenance of normotension or controlled hypotension are the aims of the perioperative care of these patients.…”

Section: Anaesthetic Considerationsmentioning

confidence: 99%

Interventional Neuroradiological Procedures—A Review for Anaesthetists

Hayman

Paleologos

Kam

2013

Anaesthesia and Intensive Care

View full text Add to dashboard Cite

Interventional neuroradiology is a rapidly expanding field, and the complexity and duration of these procedures makes anaesthetic support essential to their success. Such has been the development in this area that the American Heart Association has published a scientific statement on the indications for these procedures. A detailed understanding of patient pathology, the technical aspects of the interventions and their associated risks, and the remote location in which they are performed are important for providing expert anaesthetic care. The aim of this article is to provide a description and contemporary analysis of the common interventional neuroradiology procedures relevant to the anaesthetist. This article will cover the management of intracranial aneurysms, cerebral vasospasm following intracranial haemorrhage, intracranial and spinal arteriovenous malformations, idiopathic intracranial hypertension, carotid artery stenting, intra-arterial thrombolysis for stroke and endovascular treatment of intracranial atherosclerosis. Protection from ionising radiation and acute kidney injury are also discussed.

show abstract

“…These types of microcatheters are not compatible with DMSO. Despite the low obliteration rates observed with NBCA [20], we selected this embolic agent because of the penetration rate based on the dilution with lipiodol, the distal placement of the microcatheter, the compact nidus of the AVM, and the absence of a fistulous pattern. We used the same material for the ipsilateral AICA catheterization and embolization.…”

Section: Discussionmentioning

confidence: 99%

Endovascular Treatment of an Arteriovenous Malformation Associated with a Double Origin of the Posterior Inferior Cerebellar Artery

2021

View full text Add to dashboard Cite

Introduction: A double origin of the posterior inferior cerebellar artery (DOPICA) is a rare anatomical variant. Posterior fossa arteriovenous malformations (AVMs), especially cerebellar AVMs, are also not common. Consequently, the association of a DOPICA with a cerebellar AVM is even rare. Case Presentation: We present a rare case of a pediatric cerebellar AVM supplied by a branch of a DOPICA which was treated endovascularly with NBCA. Total obliteration was achieved in the immediate controls and at 1-year follow-up. Conclusion: Navigation through tortuous and long branches from a DOPICA is technically feasible. Although NBCA cure rates are relatively low, when the microcatheter can no longer navigate through the feeding artery, a correct dilution of NBCA with lipiodol can provide adequate penetration of this embolic agent, to obliterate the AVM nidus completely.

show abstract

Embolization of Arteriovenous Malformation with Diluted Mixture of NBCA

Cited by 21 publications

References 7 publications

Advances in Biomaterials and Technologies for Vascular Embolization

Advances in Biomaterials and Technologies for Vascular Embolization

Interventional Neuroradiological Procedures—A Review for Anaesthetists

Endovascular Treatment of an Arteriovenous Malformation Associated with a Double Origin of the Posterior Inferior Cerebellar Artery

Contact Info

Product

Resources

About